BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//DEMENTIA RESEARCHER - ECPv6.14.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:DEMENTIA RESEARCHER
X-ORIGINAL-URL:https://www.dementiaresearcher.nihr.ac.uk
X-WR-CALDESC:Events for DEMENTIA RESEARCHER
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260710T080000
DTEND;TZID=Europe/London:20260710T173000
DTSTAMP:20260706T013920
CREATED:20260615T141343Z
LAST-MODIFIED:20260616T100309Z
UID:10002289-1783670400-1783704600@www.dementiaresearcher.nihr.ac.uk
SUMMARY:NIA-AA Symposium — Enabling Precision Medicine for Alzheimer’s Disease Through Open Science
DESCRIPTION:NIA AA Symposium 2026\nEnabling Precision Medicine for Alzheimer’s Disease Through Open Science\nFriday 10 July 20268.00 am to 5.30 pm BSTInterContinental London O2 Hotel\, Peninsula West\, LondonIn person attendance only \nThe 8th Annual NIA AA Symposium will bring together researchers\, clinicians\, data scientists\, open science advocates\, and industry colleagues to explore how precision medicine and open science can advance Alzheimer’s disease and related dementias research. \nHosted as an AAIC 2026 preconference\, the symposium will feature NIA supported clinical trials and translational research programmes using precision medicine approaches to better understand disease heterogeneity\, identify new targets and biomarkers\, improve models of Alzheimer’s disease\, and support therapy development. \nAcross the day\, sessions will cover molecular subtypes and shared disease mechanisms\, environmental approaches to risk reduction and prevention\, preclinical therapy development\, clinical development\, and the creation of knowledge networks for precision medicine. \nThe programme has been jointly developed by the National Institute on Aging and the Alzheimer’s Association\, with speakers from leading institutions including NIA\, Emory University\, Rush University\, Columbia University\, University of Michigan\, The Jackson Laboratory\, University of Pittsburgh\, Harvard University\, Duke University\, University of California San Francisco\, Sage Bionetworks and the Allen Institute. \nWho should attend?\nThis event is aimed at academic\, biotech and pharmaceutical industry researchers\, clinicians\, computational biologists\, data scientists\, and others with an interest in target discovery\, biomarker discovery\, drug development\, precision medicine and open science. \nRegistration\nAAIC preconferences require separate registration. Attendees may register alongside AAIC full conference registration or as a stand alone preconference event. Registration is managed by the Alzheimer’s Association.
URL:https://www.dementiaresearcher.nihr.ac.uk/event/nia-aa-symposium-enabling-precision-medicine-for-alzheimers-disease-through-open-science/
LOCATION:InterContinental London O2 Hotel\, 1 Waterview Dr\, London\, SE10 0TW\, United Kingdom
CATEGORIES:Symposium
ATTACH;FMTTYPE=image/jpeg:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2021/09/NIA-e1642070215650.jpg
GEO:51.5028854;-0.0001096
X-APPLE-STRUCTURED-LOCATION;VALUE=URI;X-ADDRESS=InterContinental London O2 Hotel 1 Waterview Dr London SE10 0TW United Kingdom;X-APPLE-RADIUS=500;X-TITLE=1 Waterview Dr:geo:-0.0001096,51.5028854
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260710T100000
DTEND;TZID=Europe/London:20260710T170000
DTSTAMP:20260706T013920
CREATED:20260326T205154Z
LAST-MODIFIED:20260326T205230Z
UID:10002161-1783677600-1783702800@www.dementiaresearcher.nihr.ac.uk
SUMMARY:ITM2B Symposium
DESCRIPTION:How can an understudied gene teach us to fight dementia? The ITM2B Symposium is a research conference exploring clinical\, pathological and modelling advances in British dementia and other ITM2B related dementias. \nThis meeting brings together international experts to share the latest findings on disease mechanisms\, biomarkers\, and emerging approaches to understanding these rare but informative conditions. By focusing on ITM2B\, an often overlooked gene\, the symposium aims to uncover insights that may inform broader dementia research. \nDate and Location\n10 July 2026Kennedy Lecture Theatre\, ICH GOSH\, London\, UK \nThis is a hybrid event\, with options to attend in person or online. \nAttendance\n\nFree to attend\nOpen to all career stages and backgrounds\n\nSpeakers\n\nRuben Vidal\, Indiana University School of Medicine\, USA\nLuciano D’Adamio\, Rutgers Brain Health Institute\, USA\nSimon Mead\, UCL\, UK\nTamas Revesz\, UCL\, UK\nKo Woon Kim\, National University Hospital\, Jeonju\, South Korea\nJuliette Wohlschlegel\, University of Washington\, USA\n\nRegistration\nRegister by 10 June 2026 \nFor further information contact: c.arber@ucl.ac.uk \n\nRegister
URL:https://www.dementiaresearcher.nihr.ac.uk/event/itm2b-symposium/
LOCATION:UCL – Kennedy Lecture Theatre\, Institute of Child Health - Main Building\, 30 Guildford Street\, London\, Greater London\, WC1N 1EH\, United Kingdom
CATEGORIES:Conference,Online,Symposium
ATTACH;FMTTYPE=image/png:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2026/03/ITM2B-Symposium.png
GEO:51.523309;-0.120066
X-APPLE-STRUCTURED-LOCATION;VALUE=URI;X-ADDRESS=UCL – Kennedy Lecture Theatre Institute of Child Health - Main Building 30 Guildford Street London Greater London WC1N 1EH United Kingdom;X-APPLE-RADIUS=500;X-TITLE=Institute of Child Health - Main Building\, 30 Guildford Street:geo:-0.120066,51.523309
END:VEVENT
END:VCALENDAR